MONTREAL, Aug. 12, 2011 /CNW/ -- Strong comeback to profitability and Sales increase by more than 43% Symbol:  CXG.A-TSX-V www.clemex.com Shares Outstanding:  20,749,810 MONTREAL, Aug. 12, 2011 /CNW Telbec/ - Clemex Technologies Inc. (TSXV: CXG.A) announces its financial results for Fiscal Year ending April 30(th), 2011. The Corporation ends this Fiscal Year with a positive EBITDA of $699 082 when compared to a negative EBITDA of $17 052 in 2010, et ended the year with a Net Gain after taxes of $323,090 while a Net Loss of $261,520 had been posted in 2010. Sales increased by 43.7% from $3,659,129 in 2010 to $5,259,165 in 2011. The most significant increase came from International sales which surpassed last year sales by 83.8%. Gross margin slightly improved to 60.5% up from 59.3% last year. When asked to comment these results, the President and CEO, Clement Forget declared the following: "The upsurge of activity in the industrial and manufacturing sectors which had begun at the end of 2010 Fiscal year has continued during this past year enabling the Company to return to 2008 sales volume. This resumption in activity was accompanied by renewed vigour in production rate and profitability after two difficult years. We were able to end the year with a net profit of $323,090 despite the severe fluctuations of the Canadian dollar which also affects our profitability considering approximately 70% of our sales are concluded in US dollars." Mr. Forget continued:" At about halfway into this Fiscal year, marketing activities also resumed with renewed vigour given the rise in customer demand and many opportunities in the market. The Company participated in a greater number of trade shows, and its efforts generated results. On the other hand, our research project of a medical device for Hematology applications is moving along well and we should be setting up our first functional prototype unit in a Montreal hospital this coming fall.  Finally, our distribution agreement with LEICA Microsystems which began in March 2011 has not yet added to our sales significantly but it will definitely contribute to increase our business and visibility in Canada for years to come. Financial Highlights Fiscal year ended April 30(th), 2011 April 30(th), 2010 $ $ Sales 5, 259,165 3, 659,129 Gross Profit 3, 180,532 2, 169,141 60.5 % 59.3 % Total Operating Expenses 2, 692,178 2, 398,628 EBITDA 699 082 (17 052) Net Gain (Loss) & Comprehensive Income (Loss) 323,090 (261,520) Basic gain (loss) Per Share 0.016 (0.013) About Clemex Technologies, Inc. Clemex Technologies Inc. develops, manufactures and markets image analysis systems and software used by quality control and research microscopy laboratories.  Clemex customer base spans over many countries in America, Europe, Asia and encompasses major Research and Development Centers, prestigious Universities and large manufacturing industries in various fields including healthcare, automotive, aerospace, raw materials manufacturing, pharmaceuticals, mining and other sectors. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this news release.    To view this news release in HTML formatting, please use the following URL: http://www.cnw.ca/en/releases/archive/August2011/12/c3473.html p bClemex Technologies Inc, /bbr/ 800 Guimond,br/ Longueuil, QC, Canada J4G 1T5,br/ br/ Contact:br/ br/ Clément Forgetbr/ Tel: 450.651.6573br/ Email: a href="mailto:ir@clemex.com" cr="true"ir@clemex.com/a /p

Copyright